Syndax Pharmaceuticals Inc (SNDX): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| May 19, 2025 | Katkin Keith Director | 10,000 | $9.11 | $91.1K | no history |
| May 19, 2025 | Huber Martin H. Jr. Director | 5,000 | $8.99 | $45.0K | no history |
| May 19, 2025 | Botwood Nicholas A.J. Officer | 11,765 | $9.00 | $105.9K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.